Acyclovir vs Nivolumab

## Acyclovir vs Nivolumab: Overview

This comparison examines the pharmacological differences between **Acyclovir** and **Nivolumab**.

## Mechanism of Action

**Acyclovir**: Guanosine analogue inhibiting viral DNA polymerase.

**Nivolumab**: Fully human anti-PD-1 IgG4 monoclonal antibody restoring T-cell anti-tumor activity.

## Pharmacokinetics

**Half-life**: Acyclovir — 2.5-3.3 hours; Nivolumab — 27 days.

## Chemical Properties

**Molecular Formula**: Acyclovir — C8H11N5O3; Nivolumab — N/A.

**Molecular Weight**: Acyclovir — 225.2050 g/mol; Nivolumab — N/A.

**Type**: Acyclovir — Small molecule; Nivolumab — Antibody.